{
    "eid": "2-s2.0-85100011798",
    "title": "Addressing demand for recombinant biopharmaceuticals in the COVID-19 era",
    "cover-date": "2021-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Balamurugan Shanmugaraj",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 11,
    "ref-count": 23,
    "ref-list": [
        "Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): An emerging zoonotic respiratory pathogen in humans",
        "Perspectives on monoclonal antibody therapy as potential therapeutic intervention for coronavirus disease-19 (COVID-19)",
        "Advances in plant molecular farming",
        "Production of antibodies in transgenic plants",
        "Plant molecular farming: Much more than medicines",
        "Shotguns vs lasers: Identifying barriers and facilitators to scaling-up plant molecular farming for high-value health products",
        "Emergence of novel coronavirus 2019-nCoV: Need for rapid vaccine and biologics development",
        "Plant-made vaccine antigens and biopharmaceuticals",
        "Plant-made oral vaccines against human infectious diseases-Are we there yet?",
        "Plant-made vaccines and reagents for the One Health initiative",
        "Plant molecular farming of virus-like nanoparticles as vaccines and reagents",
        "Plant molecular farming: A viable platform for recombinant biopharmaceutical production",
        "Development of systems for the production of plant-derived biopharmaceuticals",
        "Overcoming low yields of plant-made antibodies by a protein engineering approach",
        "Plant molecular farming-Integration and exploitation of side streams to achieve sustainable biomanufacturing",
        "Molecular farming in plants: Host systems and expression technology",
        "Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies",
        "Critical analysis of the commercial potential of plants for the production of recombinant proteins",
        "Potential applications of plant biotechnology against SARS-CoV-2",
        "Will plant-made biopharmaceuticals play a role in the fight against COVID-19?",
        "What does plant-based vaccine technology offer to the fight against COVID-19?",
        "Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Second Century Fund"
    ]
}